Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: Relationship between homocysteine levels and hyperinsulinemia

European Journal of Endocrinology

Volumn 151, Issue 4, 2004, Pages 483-489

  Setola, Emanuela ^e   Monti, Lucilla Domenica ^a   Galluccio, Elena ^a   Palloshi, Altin ^b   Fragasso, Gabriele ^b   Paroni, Rita ^c   Magni, Fulvio ^d   Sandoli, Emilia Paola ^a   Lucotti, Pietro ^e   Costa, Sabrina ^a   Fermo, Isabella ^c   Galli Kienle, Marzia ^d   Origgi, Anna ^e   Margonato, Alberto ^b   Piatti, PierMarco ^e  

^a Diabetol/Endocrinol Metab Dis U   (Italy)

^b Invasive Cardiology Unit   (Italy)

^c Ospedale San Rafaele   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e Medicine Division   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CYANOCOBALAMIN; CYCLIC GMP; DIMETHYLARGININASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; HOMOCYSTEINE; INSULIN; ISOSORBIDE DINITRATE; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET THERAPY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; FEMALE; FUNCTIONAL ASSESSMENT; HOMEOSTASIS; HUMAN; HYPEREMIA; HYPERHOMOCYSTEINEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; ISCHEMIA; MALE; METABOLIC SYNDROME X; MODEL; PARALLEL DESIGN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VASODILATATION;

AGED; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; FOLIC ACID; HEMATINICS; HOMOCYSTEINE; HUMANS; HYPERINSULINISM; MALE; METABOLIC SYNDROME X; RISK FACTORS; VITAMIN B 12;

EID: 7244231126     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510483     Document Type: Article

References (44)

1. Mayer EL, Jacobsen DW & Robinson K. Homocysteine and coronary atherosclerosis. Journal of the American College of Cardiology 1996 27 517-527.
2. Wall RT, Harlan JM, Harker LA & Striker GE. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thrombosis Research 1980 18 113-121.
3. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D & Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. Journal of Clinical Investigation 1993 91 308-318.
4. Tawakol A, Omland T, Gerhard M, Wu J & Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997 95 1119-1121.
5. Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, Newcombe RG & Lewis MJ. Oral folate enhances endothelial function in hyperhomocysteinaemic subjects. European Journal of Clinical Investigation 1999 29 659-662.
6. Woo KS, Chook P, Lolin YI, Sanderson JE, Metreweli C & Celermajer DS. Folic acid improves arterial endothelial function in adults with hyperhomocysteinemia. Journal of the American College of Cardiology 1999 34 2002-2006.
7. Vallance P, Leone A, Calver A, Collier J & Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. Journal of Cardiovascular Pharmacology 1992 20 S60-S62.
8. Heitzer T, Schlinzig T, Krohn K, Meinertz T & Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001 104 2673-2678.
9. Beckman JS & Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. American Journal of Physiology 1996 271 C1424-C1433.
10. Stroes ES, van Faassen EE, Yo M, Martasek P, Boer P, Govers R & Rabelink TJ. Folic acid reverts dysfunction of endothelial nitric oxide synthase. Circulation Research 2000 86 1129-1134.
11. Gori T, Burnstein JM, Ahmed S, Miner SE, Al Hesayen A, Kelly S & Parker JD. Polic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation 2001 104 1119-1123.
12. Wilmink HW, Stroes ES, Erkelens WD, Gerritsen WB, Wever R, Banga JD & Rabelink TJ. Influence of folic acid on postprandial endothelial dysfunction. Arteriosclerosis Thrombosis and Vascular Biology 2000 20 185-188.
13. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D'Agostino RB Sr, Wilson PW & the Framingham Offspring Study. Fasting plasma homocysteine levels in the insulin resistance syndrome. Diabetes Care 2001 24 1403-1410.
14. Gillum R. Distribution of serum total homocysteine and its association with diabetes and cardiovascular risk factors of the insulin resistance syndrome in Mexican American men: the Third National Health and Nutrition Examination Survey. Nutrition Journal 2003 2 6-13.
15. Giltay EJ, Hoogeveen EK, Elbers JMH, Gooren LJG, Asscheman H & Stehouwer CDA. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 1998 139 197-198.
16. Emoto M, Kanda H, Shoji T, Kawagishi T, Komatsu M, Mori K, Tahara H, Ishimura E, Inaba M, Okuno Y & Nishizawa Y. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 2001 24 533-538.
17. Fonseca VA, Fink LM & Kern PA. Insulin sensitivity and plasma homocysteine concentrations in non diabetic obese and normal weight subjects. Atherosclerosis 2003 167 105-109.
18. Oron-Herman M, Rosenthal T & Sela BA. Hyperhomocysteinemia as a component of syndrome X. Metabolism 2003 52 1491-1495.
19. Schachter M, Raziel A, Friedler S, Strassburger D, Bern O & Ron-El R. Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine. Human Reproduction 2003 18 721-727.
20. Laivuori H, Kaaja R, Turpeinen U, Viinikka L & Ylikorkala O. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstetrics and Gynecology 1999 93 489-493.
21. Abbasi F, Facchini F, Humphreys MH & Reaven GM. Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin mediated glucose disposal. Atherosclerosis 1999 146 175-178.
22. Wulfelle MG, Kooy A, Lehert P, Bets D, Ogterop JC, Borger van de Burg B, Donker AJ & Stehouwer CD. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. Journal of Internal Medicine 2003 254 455-463.
23. Pouwels MJ, Den Heijer M, Blom HJ, Tack CJ & Hermus AR. Improved insulin sensitivity and metabolic control in type 2 diabetes does not influence plasma homocysteine. Diabetes Care 2003 26 1637-1639.
24. Gursu MF, Baydas G, Cikim G & Canatan H. Insulin increases homocysteine levels in a dose dependent manner in diabetic rats. Archives of Medical Research 2002 33 305-307.
25. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497.
26. Quinlivan EP, McPartlin J, McNulty H, Ward M, Strain JJ, Weir DG & Scott JM. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 2002 359 227-228.
27. Capaldo B, Guardasole V, Pardo F, Matarazzo M, Di Rella F, Numis F, Merola B, Longobardi S & Sacca L. Abnormal vascular reactivity in growth hormone deficiency. Circulation 2001 103 520-524.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985 28 412-419.
29. Piatti PM, Fragasso G, Monti LD, Setola E, Lucotti P, Fermo I, Paroni R, Galluccio E, Pozza G, Chierchia S & Margonato A. Acute intravenous L-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms. Circulation 2003 107 429-436.
30. Moat SJ, Lang D, McDowell IFW, Clarke ZL, Madhavan AK, Lewis MJ & Goodfellow J. Folate, homocysteine, endothelial function and cardiovascular disease. Journal of Nutritional Biochemistry 2004 15 64-79.
31. Najib S & Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. Journal of Molecular Endocrinology 2001 27 85-91.
32. Piatti PM, Di Mario C, Monti LD, Fragasso G, Sgura F, Caumo A, Setola E, Lucotti P, Galluccio E, Ronchi C, Origgi A, Zavaroni I, Margonato A & Colombo A. Association of insulin resistance, hyperinsulinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003 108 2074-2081.
33. Orio F Jr, Palomba. S, Di Biase S, Colao A, Tauchmanova L, Savastano S, Labella D, Russo T, Zullo F & Lombardi G. Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2003 88 673-679.
34. Gallistl S, Sudi K, Mangge H, Erwa W & Borkenstein M. Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care 2000 23 1348-1352.
35. Stühlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM & Tsao PS. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002 287 1420-1426.
36. Asagami T, Abbasi F, Stühlinger M, Lamendola C, McLaughin T, Cooke JP, Reaven GM & Tsao PS. Metformin treatment lowers asymmetric dimethylarginine concentration in patients with type 2 diabetes. Metabolism 2002 51 843-846.
37. Holven KB, Haugstad TS, Holm T, Aukrust P, Ose L & Nenseter MS. Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects. British Journal of Nutrition 2003 89 359-363.
38. Sydow K, Schwedhelm E, Arakawa N, Bode-Boger SM, Tsikas D, Hornig B, Frolich JC & Boger RH. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. Cardiovascular Research 2003 57 244-252.
39. Stühlinger M, Tsao PS, Her JH, Kimoto M, Balint RF & Cooke JP. Homocysteine impairs the nitric oxide synthase pathway. Role of asymmetric dimethylarginine. Circulation 2001 104 2569-2575.
40. Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D & Bode-Boger SM. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells. Circulation Research 2000 87 99-105.
41. Piatti PM, Monti LD, Valsecchi G, Magni E, Setola E, Marchesi F, Galli-Kienle M, Pozza G & Alberti KG. Long term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 2001 24 875-880.
42. Sasaki K, Duan J, Murohara T, Ikeda H, Shintani S, Shimada T, Akita T, Egami K & Imaizumi T. Rescue of hypercholesterolemia-related impairment of angiogenesis by oral folate supplementation. Journal of the American College of Cardiology 2003 42 364-372.
43. Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher T & Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. Journal of Clinical Investigation 1997 99 41-46.
44. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ & Goodfellow J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002 105 22-26.